Multipotent mesenchymal stromal cells (MSCs) are bone marrow-derived cells of nonhematopoietic origin with immunoregulatory properties. Although some functions of MSCs have been identified, there are still features that are not explained thus far. The aim of the present study was to identify novel factors involved in MSC-mediated inhibition of T-cell proliferation. We here demonstrate that the surface molecule CD39 is coexpressed in concert with CD73 on murine MSCs catalyzing the generation of adenosine, which can directly act on activated T cells via the adenosine A2A receptor. Blocking of the adenosine pathway either by the A2A receptor antagonist SCH58261 or the specific CD39 inhibitor polyoxotungstate 1 (POM-1) blocked MSC-mediated suppression of T-cell proliferation almost completely. We conclude that CD39/CD73 coexpression is a novel important component of the immunoregulatory functions of murine MSCs. Our findings may both be important to improve our understanding of MSC function and for the development of immunomodulatory cellular therapies.
INTRODUCTION
nosuppression after allogenic transplantation. MSC treatment prolongs skin allograft survival in baboons (2) , prevents rejection of allogenic melanoma cells in mice Multipotent mesenchymal stromal cells (MSCs) are adult stem cells of nonhematopoietic origin in the bone (16), and attenuates graft-versus-host disease in mice and in humans (35, 51) . Therefore, MSCs seem to affect marrow. MSCs, first described by Friedenstein et al. as "colony-forming unit fibroblasts," are undifferentiated only alloreactive responses without compromising other reactions of the recipient immune system (4) . Several cells with high self-renewal capacity that have the potential to give rise to cells of different lineages (21) .
features found in MSCs contribute to their immunoregulatory effects. Suppression of allogenic immune re-They are typically isolated from bone marrow but can be purified from other adult tissues such as adipose tissue, sponses appears to be mediated both by cell contact and by soluble factors depending on the experimental condi-umbilical cord blood, spleen, lung, and skeletal muscle as well (8, 21, 55) . MSCs are relatively rare in bone mar-tions (31, 59) . In human MSCs, it has been shown that immunosuppression is at least partly mediated by the row (0.001-0.01%) but offer the advantage that they can be easily cultured and expanded in vitro (21, 43) . One of expression of the tryptophan-degrading enzyme indoleamine 2,3-dioxygenase (IDO) and the use of an IDO the major functions of MSCs in vivo is to provide an environment for the maturation of hematopoietic cells in inhibitor reduces but does not completely abrogate immunosuppression (30, 38) . Other factors such as trans-the bone marrow and to repair damaged tissues (19, 43) .
A number of studies showed that MSCs possess im-forming growth factor-β1 (TGF-β1), hepatocyte growth factor (HGF), prostaglandin E 2 (PGE 2 ), or matrix metal-munomodulatory properties in vitro and in vivo, which makes them a promising alternative to standard immu-loproteinase-2 and -9 (MMP-2 and MMP-9) were de-scribed to suppress T-cell proliferation (13, 14, 40, 41) .
Characterization of Multipotent MSCs Apparently different mechanisms mediate the regulatory
For flow cytometric characterization cells were decapacity of MSCs depending on the type of stimulating tached by incubation with EDTA. Unspecific binding agent. While TGF-β1 and HGF seem to be most imporsites were blocked by preincubation with Fc-Block tant after allogenic stimulation, PGE 2 dominates the sup-(eBioscience, Frankfurt, Germany). The following PEpressive function after mitogenic stimulation (1, 15, 46) . or FITC-conjugated monoclonal antibodies were used Additionally, the mechanisms of immunomodulation by for staining: CD117-FITC, CD44-FITC, CD45-FITC, MSCs may vary depending on the method of isolation CD62L-FITC, CD31-PE (Immunotools, Friesoythe, Gerand culture conditions. many), VCAM-FITC, CD140b-PE, CD105-PE, CD34-PE, In the present study we tested the effects of murine CD73-PE, CD39-PE, CD90.2-PE, Flk1-PE, ICAM-PE, MSCs on suppression of T-cell proliferation. We show CD133-FITC (eBioscience), Sca1-PE (BD Biosciences, for the first time that the generation of adenosine from Heidelberg, Germany), CD29-FITC (BioLegend, Echextracellular ATP/ADP is an important mechanism ining, Germany). Antibody specificity was controlled usvolved in suppression of T-cell proliferation. This effect ing matched isotype antibodies. Flow cytometry was is mediated by the novel MSC cell surface marker performed using FACS Calibur instrumentation (BD CD39, which catalyses the production of adenosine in Biosciences). Data was analyzed with WinMDI 2.8 softconcert with CD73 (17) . Our data indicate that murine ware ( Joseph Trotter).
MSCs share features of immunoregulatory T cells,
Differentiation Assays which has intriguing implications for the development of cell-based immunosuppressive therapies in autoim-To demonstrate that the isolated MSCs possess multimune diseases or after organ transplantations. potent abilities, MCSs were differentiated into osteoblasts, adipocytes, and chondrocytes using specific stimuli. For MATERIALS AND METHODS osteoblastic differentiation the cells were cultured for 18 Animals days in DMEM (1.0 g/L glucose) supplemented with dexamethasone (0.1 µM), β-glycerophosphate (10 mM), Five-to 16-week-old male BALB/c and C57BL/6 and ascorbic acid (0.3 mM) and assayed by Von Kossa mice (Harlan-Winkelmann, Borchen, Germany) were staining. To induce adipogenic differentiation cells were used for the experiments. Animal procedures were contreated over 10 days with DMEM (4.5 g/L glucose) supducted in accordance with the German Law on the use plemented with 10% FCS, isobutyl-methylxanthine (0.1 of Laboratory Animals and approved by the regional aumg/ml), indomethacin (200 µM), dexamethasone (1 thorities.
µM), and insulin (10 µg/ml). Differentiation was de-Isolation and Culture of Bone-Marrow (BM)-Derived tected by Oil Red-O staining. For chondrocytic differen-Multipotent MSCs tiation, cells were incubated according to the previously Murine MSCs were isolated and expanded using a described micromass culture technique (11, 49) . Briefly, modification of the methods of da Silva Meirelles et al.
10 µl of a concentrated cell suspension (8 × 10 6 cells/ (8) and Tropel et al. (52). Bone marrow from male ml) were plated into the center of each well of a 12-well BALB/c mice was extracted by flushing out femurs and culture plate. The cells were allowed to attach at 37°C tibias using a 27-gauge needle. Red blood cells were for 2 h, overlaid with differentiation medium [α-MEM removed by hypotonic lysis and the remaining cells with 1% FCS, 6.25 µg/ml insulin, 50 nM ascorbate-2were cultured at a density of 1.4 × 10 6 /cm 2 in isolation phosphate, 10 ng/ml human TGF-β1 (Peprotech, Hammedium consisting of low glucose DMEM suppleburg, Germany), and 1% P/S] and incubated for 2 mented with 10% fetal calf serum (FCS), 1% penicillin/ weeks, followed by staining with Alcian blue (all chemistreptomycin (P/S), and 3.7 g/L HEPES (Invitrogen, cals from Sigma, Munich, Germany). Karlsruhe, Germany). Nonadherent cells were discarded RT-PCR 4 days later. At day 7 CD45-positive cells were removed by magnetic sorting with CD45 magnetic beads (Mil-MSCs were plated in six-well plates at a density of 3 × 10 4 /well, cultured overnight, and then stimulated tenyi, Bergisch-Gladbach, Germany) according to the manufacturer's instructions. CD45-negative cells were with interferon-γ (IFN-γ) (100 U/ml) ± tumor necrosis factor-α (TNF-α; 10 ng/ml; Peprotech) for 48 h. Mes-seeded at a density of 8 × 10 3 /cm 2 in isolation medium supplemented with recombinant murine EGF (10 ng/ml; senger RNA was isolated after stimulation using the High Pure RNA Isolation Kit (Roche, Mannheim, Ger-Tebu-Bio, Offenbach, Germany) and recombinant human PDGF-BB (1 ng/ml; R&D Systems, Wiesbaden, many) according to manufacturer's instructions and reversely transcribed with the Omniscript RT kit (Qiagen, Germany). In some experiments formalin-fixed MSCs (4% PFA for 20 min) were used.
Hilden, Germany). cDNA was analyzed for the expres-sion of IDO and β-actin. The following PCR primer sets functional analysis of MSC-mediated effects: the adenosine A2A receptor antagonist SCH58261 (25 µM), the were used: 5′-ACCCACACTGTGCCCATCTA-3′ and 5′-GCCACAGGATTCCATACCCA-3′ (for β-actin); 5′-CD39 inhibitor POM-1 (50 and 100 µM; all chemicals from Sigma), an anti-HGF receptor antibody (10 µg/ml; GTACATCACCATGGCGATTG-3′ and 5′-GCTTTCG TCAAGTCTTCATTG-3′ (for IDO).
GeneTex/Biozol, Eching, Germany), and a monoclonal anti-TGF-β1 antibody (1 µg/ml; Abcam, Cambridge, Western Blot Analysis UK). Specificity of the used antibodies was controlled by using matched isotype controls. Expression of IDO by murine MSCs on the protein level was analyzed by Western Blot. MSCs were plated and stimulated for 48 h with IFN-γ (100 U/ml) ± TNF-α Transwell Experiments (10 ng/ml). Cells were lysed in RIPA buffer containing C57BL/6 T cells (2 × 10 5 ) were plated in the lower protease inhibitors, applied to 10% SDS gel electrophochamber of a 24-well transwell plate (0.4 µm pore size; resis according to the method of Laemmli (33) , and
Corning, Schiphol-Rijk, The Netherlands) in a volume transferred to Hybond-P PVDF membrane (GE Healthof 600 µl MLR medium. Mitomycin C-treated MSCs care, Munich, Germany). Recombinant mouse IDO was (2 × 10 5 ) were plated in the upper chamber. T-cell proused as positive control (0.25 µg; Alexis/Axxora, Lörliferation was induced by the addition of ConA (5 µg/ rach, Germany). The membrane was blocked in Tris ml) to each well 24 h after plating. After 4 days cells buffered saline (TBS) with 1% Tween-20 and 5% skim from the lower chamber were transferred to a 96-well milk and incubated with an anti-mouse-IDO monoclonal round-bottom plate in triplicate (100 µl/well). Medium antibody (1:5000, clone: mIDO-48; BioLegend) at 4°C (60 µl) from the transwell cultures was added to a final overnight. The membrane was washed, incubated with volume of 160 µl/well. The cells were pulsed with 1 µCi alkaline-phosphatase-conjugated goat-anti-rat-Ig (1:2000;
[ 3 H]thymidine (GE Healthcare) and harvested 18 h later. BioLegend) and stained with alkaline phosphatase substrate NBT/BCIP (Roche).
Malachite Green Assay for the Detection of Ectonucleotidase Activity Kynurenine Measurement in Cell Culture Supernatants
Ectonucleotidase activity was measured in MSCs Analysis of the tryptophan catabolite kynurenine in without addition of T cells using phosphate generation cell culture supernatants was used to determine IDO acas the readout. The assay was performed as described tivity in murine MSCs according to a method of Däubepreviously by Baykov MSCs were plated in 24-well plates and used for measuring ectonucleotidase activity at 80% confluency.
T-Cell Proliferation Assay
Phosphate levels were determined from standard curves Proliferation assays were performed in 96-well using increasing concentrations of KH 2 PO 4 . round-bottom plates in a total volume of 160 µl MLR medium consisting of Iscove basal medium (Biochrom, Measurement of Adenosine Production by High Berlin, Germany), 10% FCS, 1% P/S, 50 µM β-mercap-Performance Liquid Chromatography (HPLC) toethanol (Gibco, Paisley, UK) in triplicate. MSCs were treated with 50 µg/ml mitomycin C (Sigma) for 2 h to For analysis of adenosine in cell culture supernatants various numbers of MSCs were incubated for 45 min at prevent cell proliferation, washed three times, and then plated at a density of 0.5 × 10 5 cells/well. T cells were 37°C with 50 µM ATP in phosphate-free incubation buffer (20 mM HEPES, pH 7.5, 10 mM glucose, 5 mM purified from C57BL/6 splenocytes by magnetic activated cell sorting (MACS) using CD90 MicroBeads KCl, 120 mM NaCl, 2 mM CaCl 2 , 5 mM tetramisole; all chemicals from Sigma). Supernatants were taken, (Miltenyi) according to the manufacturer's instructions. Sorted cells were >95% positive for CD45 excluding evaporated under N 2 , resuspended in 200 µl H 2 O bidest., and analyzed by HPLC. Chromatographic analysis was contamination with splenic MSCs. C57BL/6 T cells (responder cells) were plated at 0.5 × 10 5 . T cells were performed on a Shimadzu LC-10 AD instrument. A SPD 20AV detector was used with a LiChrospher RP 18e 5 stimulated after 24 h with 5 µg/ml concanavalin A (ConA; Sigma). After an additional 72 h, 1 µCi [ 3 H]thy-µm guard and a LiChrospher 250-4, 5 µm RP 18e column (Merck, Darmstadt, Germany). Adenosine was midine (Perkin-Elmer, Rodgau, Germany) was added to each well and incubated for another 18 h. Cells were measured isocratically with 7% (v/v) acetonitril in 17 mmol/L phosphate buffer as mobile phase, with a flow harvested onto filter plates (Perkin-Elmer) and [ 3 H]thymidine uptake was measured on a TopCount beta counter rate of 1.0 ml/min. Absorbance was measured at 260 nm. Retention time was 7.5 min. Class VP software was (Perkin-Elmer).
The following inhibitors or antibodies were used for used for system control and data analysis.
Statistical Analysis MSCs Strongly Inhibit T-Cell Proliferation
Purified T cells from C57BL/6 mice were stimulated Statistical analysis was performed by t-test using with ConA and cultured with or without BALB/c MSCs. Prism software (GraphPad Software, San Diego, CA, MSCs were used as unstimulated cells or prestimulated USA). Differences were considered statistically signifiwith IFN-γ or IFN-γ + TNF-α. As shown in Figure 2A , cant at p < 0.05. In cases where multiple comparisons MSCs suppressed T-cell proliferation significantly by up were made, a Bonferroni correction was performed. A to 75%, reducing proliferation from 30289 ± 9304 to value of p < 0.05 was considered significant. Data are 7695 ± 4638 cpm. No significant differences in their presented as the mean value ± SD of at least three indesuppressive potential were detected between unstimupendent experiments. lated or the two groups of prestimulated MSCs. MSCs alone did not proliferate. Formalin-fixed MSCs had no RESULTS suppressive effect on T cells, indicating that metaboli-Phenotypic Characterization of Multipotent MSCs cally active MSCs are needed for the suppressive activ-Murine MSCs were generated from bone marrow of ity (Fig. 2B ). This effect was not dependent on direct BALB/c mice. They constitute a rapidly proliferating contact between T cells and MSCs because suppression adherent cell population with fibroblast-like morphology of T-cell proliferation was still present after cell separathat can be cultured for many passages in vitro (>60) in tion using transwell chambers (Fig. 2C ). contrast to human MSCs, which often stop proliferating
Suppression of Mitogen-Activated T Cells by MSCs after 4-15 passages (14,54). Multipotency of MSCs was
Is Not Mediated by HGF, TGF-β, or IDO confirmed by their ability to differentiate into chondrocytes, adipocytes, and osteoblasts using specific stimuli Previous studies have shown that the immunoregulatory abilities of MSCs can be partly explained by the ( Fig. 1A-D) . FACS analysis showed that MSCs were positive for the MSC-associated markers CD105, CD73, expression of the tryptophan-degrading enzyme IDO, PGE 2 , and the secretion of TGF-β and HGF, respec-CD140b (PDGF receptor), CD29, Sca-1, and CD44, but negative for CD45 and CD31 excluding contamination tively (9,22,23,48). PGE 2 as well as HGF and TGF-β could be detected in cell culture supernatants of BALB/ by hematopoietic or endothelial cells (Fig. 1E ). CD90 and VCAM were weakly expressed. The cells did not c MSCs (data not shown). In blocking experiments using monoclonal antibodies against TGF-β and the HGF re-express CD117, CD62L, CD133, CD34, CD25, ICAM, or Flk1.
ceptor no significant influence on T-cell proliferation was observed (Fig. 3A) . Only minimal expression of man MSCs, which produced high levels of kynurenine after IFN-γ stimulation (data not shown).
IDO was detected by RT-PCR in unstimulated cells but mRNA levels increased after stimulation of MSCs with
MSCs Express CD39 and Generate IFN-γ or IFN-γ + TNF-α. However, no expression of Immunosuppressive Adenosine IDO protein was detected by Western blot (Fig. 3B) . Consistent with this finding, kynurenine, the end product Adenosine generation stimulated by hypoxia, organ injury, traumatic shock, or at sites of inflammation is in of tryptophan degradation (9), was not detected in supernatants of our MSCs. This was in sharp contrast to hu-part mediated by the action of the two sequential en- zymes: CD39 and CD73. The effect of adenosine is eration of adenosine and thereby promoting strong immunosuppression of effector T cells. This mechanism based on the engagement of the corresponding adenosine receptor A2A expressed by T cells. FACS analysis has been recently identified to play a major role in the immunomodulatory activity of regulatory T cells (Tregs) showed that isolated MSCs expressed not only the wellknown surface marker CD73 but also CD39, which rep- (5, 10, 28) . We here demonstrate for the first time that BALB/c MSCs share these important functions for the resents the rate-limiting enzyme in the sequential degradation of ATP to adenosine (Fig. 4A) (10) . MSCs actively modulation of inflammatory immune responses with Treg cells and that the expression of enzymatic active catabolize ATP to adenosine and phosphate as shown by measurement of adenosine by HPLC and measurement CD39/CD73 is a major player by which MSCs can downregulate mitogen-induced T-cell proliferation. of phosphate by malachite green assay (Fig. 4B, C) . The formation of phosphate could be blocked in a dose-
In the present study we investigated immunosuppressive activity of bone marrow-derived MSCs on allogenic dependent manner by addition of the specific CD39 inhibitor POM-1 (Fig. 4C ). POM-1 as a polyoxometalate mitogen stimulated T cells. Previous studies reported that several pathways are involved in MSC immunomo-belongs to a new class of NTPDase inhibitors that have recently been described to be highly specific and more dulation, including secretion of anti-inflammatory cytokines TGF-β1 and HGF, the formation of PGE 2 , and the potent than conventional inhibitors such as ARL67156 (39, 56) . We further investigated the role of CD39/ expression of IDO. In our studies we observed that HGF and TGF-β1 play only a minor role in our experimental CD73-dependent adenosine production on suppression of T-cell proliferation in a mixed lymphocyte reaction setting. The discrepancies to some previous studies may be explained by differences in culture conditions for the by using POM-1 and the adenosine A2A receptor antagonist SCH58261. Both POM-1 and SCH58261 were isolation of MSCs and the factors used to stimulate Tcell proliferation. While TGF-β1 and HGF seem to be able to significantly decrease MSC-mediated inhibition of T-cell proliferation (Fig. 5A, B) . most important after allogenic stimulation, they do not play a role after mitogenic stimulation (1, 14, 45, 46) .
DISCUSSION
Expression of the tryptophan-degrading enzyme IDO has been described in some studies as mediator of MSC-MSCs are multipotent cells with a high immunomodulatory capacity that is mediated by soluble factors and associated immunosuppression (18,38). Other experiments could not confirm these results. In particular, ex-cell surface molecules. Here, we identified that MSCs isolated from bone marrow of BALB/c mice express the pression of IDO by murine MSCs is quite controversial (30, 47, 53) . In the present study we demonstrate that ectonucleotidases CD39 and CD73, supporting the gen- BALB/c MSCs only express IDO at the mRNA but not ings of Erdmann et al., who showed that the activation of the adenosine A2A receptor on T cells is independent on the protein level, and therefore do not possess tryptophan degrading properties as assessed by the lack of ky-of the presence of dendritic cells (20). The appearance of extracellular nucleoside triphos-nurenine production. Using similar culture conditions we were able to isolate human MSCs with high expres-phates (NTP) is a well-known indicator of tissue and cell damage that activates immune and endothelial cells sion of functional active IDO (data not shown). These findings support the hypothesis that there are major spe-and induces inflammatory responses. This reaction is controlled and counteracted by the degradation of NTP cies differences in MSC properties.
To further characterize MSC functions, we studied by specific ectonucleotidases on the surface of various cells. CD39 is a member of this enzyme family and is expression of cell surface molecules involved in the modulation of cellular immune responses. Recently, sev-mainly expressed on immune cells such as B cells, dendritic cells, and subsets of T cells (10). Our findings on eral groups independently reported on regulatory CD4/ CD25, Foxp3-positive Tregs expressing CD73 and CD39 and CD73 expression on MSCs suggest that murine MSCs may be involved in downregulation of tissue CD39 (5, 10, 28) . Coexpression of the phosphohydrolytic enzymes CD73/CD39 on the cell surface of Treg cells inflammation by the generation of adenosine. There is general agreement that adenosine inhibits T-lymphocyte was shown to catalyze the sequential generation of adenosine by degradation of extracellular ATP/ADP to 5′-activation and effector functions and thereby has strong anti-inflammatory effects, can limit exaggerated im-AMP (CD39) and conversion of 5′-AMP to adenosine (CD73) (17, 60) leading to strong downregulation of T-mune reactions, and can protect tissue from cell damage (6, 25) . Sensitivity of T cells to adenosine-mediated inhi-cell proliferation and a decreased secretion of proinflammatory cytokines (7,20,42). Since CD73 is a characteris-bition depends on the expression of the A2A receptor regulated by their state of activation. Expression is high-tic molecule expressed on MSCs, we here analyzed the presence of CD39 and the generation of bioactive aden-est in effector cells, decreases in memory cells, and is lowest in naive cells (50) . Activated T cells with high osine. We provide evidence that both molecules, CD39 and CD73, are constitutively expressed by BALB/c inflammatory potential may possess the highest susceptibility to adenosine mediated suppression. Our data may MSCs leading to the generation of adenosine. Our blocking experiments with a specific CD39 inhibitor and provide a novel explanation for the beneficial effects of MSC treatment on tissue destruction described in animal a specific A2A receptor blocker revealed that adenosine exerts its effect directly on T cells even in the absence models of myocardial infarction, organ transplantation, or cell regeneration ( 29, 34, 57) . Therefore, the relevance of this novel mecha- 
